Medical Care
Global Prostate Cancer Molecular Diagnostics Market Research Report 2025
- Jul 08, 25
- ID: 347415
- Pages: 72
- Figures: 78
- Views: 1
The global market for Prostate Cancer Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A molecular approach for diagnosing prostate cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Molecular Diagnostics.
The Prostate Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Foundationmedicine
Genetech
Gpmedical
Premed
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A molecular approach for diagnosing prostate cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Molecular Diagnostics.
The Prostate Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Foundationmedicine
Genetech
Gpmedical
Premed
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Prostate Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Prostate Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Prostate Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Molecular Diagnostics Market Dynamics
2.3.1 Prostate Cancer Molecular Diagnostics Industry Trends
2.3.2 Prostate Cancer Molecular Diagnostics Market Drivers
2.3.3 Prostate Cancer Molecular Diagnostics Market Challenges
2.3.4 Prostate Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Molecular Diagnostics Revenue
3.4 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Prostate Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Prostate Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Prostate Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
6.2 North America Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Prostate Cancer Molecular Diagnostics Introduction
11.1.4 Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.2.5 Foundationmedicine Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Prostate Cancer Molecular Diagnostics Introduction
11.3.4 Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.3.5 Genetech Recent Development
11.4 Gpmedical
11.4.1 Gpmedical Company Details
11.4.2 Gpmedical Business Overview
11.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Introduction
11.4.4 Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.4.5 Gpmedical Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Prostate Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.6.5 Berryoncology Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Prostate Cancer Molecular Diagnostics Introduction
11.7.4 Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.7.5 Gene+ Recent Development
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Prostate Cancer Molecular Diagnostics Introduction
11.8.4 Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.8.5 Annoroad Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Prostate Cancer Molecular Diagnostics Introduction
11.9.4 Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.9.5 Topgen Recent Development
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Prostate Cancer Molecular Diagnostics Introduction
11.10.4 Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.10.5 Geneis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Prostate Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Prostate Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Prostate Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Molecular Diagnostics Market Dynamics
2.3.1 Prostate Cancer Molecular Diagnostics Industry Trends
2.3.2 Prostate Cancer Molecular Diagnostics Market Drivers
2.3.3 Prostate Cancer Molecular Diagnostics Market Challenges
2.3.4 Prostate Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Molecular Diagnostics Revenue
3.4 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Prostate Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Prostate Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Prostate Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
6.2 North America Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Prostate Cancer Molecular Diagnostics Introduction
11.1.4 Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.2.5 Foundationmedicine Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Prostate Cancer Molecular Diagnostics Introduction
11.3.4 Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.3.5 Genetech Recent Development
11.4 Gpmedical
11.4.1 Gpmedical Company Details
11.4.2 Gpmedical Business Overview
11.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Introduction
11.4.4 Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.4.5 Gpmedical Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Prostate Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.6.5 Berryoncology Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Prostate Cancer Molecular Diagnostics Introduction
11.7.4 Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.7.5 Gene+ Recent Development
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Prostate Cancer Molecular Diagnostics Introduction
11.8.4 Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.8.5 Annoroad Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Prostate Cancer Molecular Diagnostics Introduction
11.9.4 Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.9.5 Topgen Recent Development
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Prostate Cancer Molecular Diagnostics Introduction
11.10.4 Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025)
11.10.5 Geneis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Prostate Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Prostate Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Prostate Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Prostate Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Prostate Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Prostate Cancer Molecular Diagnostics Market Trends
Table 13. Prostate Cancer Molecular Diagnostics Market Drivers
Table 14. Prostate Cancer Molecular Diagnostics Market Challenges
Table 15. Prostate Cancer Molecular Diagnostics Market Restraints
Table 16. Global Prostate Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Prostate Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Prostate Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Prostate Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Prostate Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Prostate Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Prostate Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Qiagen Company Details
Table 49. Qiagen Business Overview
Table 50. Qiagen Prostate Cancer Molecular Diagnostics Product
Table 51. Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Qiagen Recent Development
Table 53. Foundationmedicine Company Details
Table 54. Foundationmedicine Business Overview
Table 55. Foundationmedicine Prostate Cancer Molecular Diagnostics Product
Table 56. Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Foundationmedicine Recent Development
Table 58. Genetech Company Details
Table 59. Genetech Business Overview
Table 60. Genetech Prostate Cancer Molecular Diagnostics Product
Table 61. Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Genetech Recent Development
Table 63. Gpmedical Company Details
Table 64. Gpmedical Business Overview
Table 65. Gpmedical Prostate Cancer Molecular Diagnostics Product
Table 66. Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Gpmedical Recent Development
Table 68. Premed Company Details
Table 69. Premed Business Overview
Table 70. Premed Prostate Cancer Molecular Diagnostics Product
Table 71. Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Premed Recent Development
Table 73. Berryoncology Company Details
Table 74. Berryoncology Business Overview
Table 75. Berryoncology Prostate Cancer Molecular Diagnostics Product
Table 76. Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Berryoncology Recent Development
Table 78. Gene+ Company Details
Table 79. Gene+ Business Overview
Table 80. Gene+ Prostate Cancer Molecular Diagnostics Product
Table 81. Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Gene+ Recent Development
Table 83. Annoroad Company Details
Table 84. Annoroad Business Overview
Table 85. Annoroad Prostate Cancer Molecular Diagnostics Product
Table 86. Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Annoroad Recent Development
Table 88. Topgen Company Details
Table 89. Topgen Business Overview
Table 90. Topgen Prostate Cancer Molecular Diagnostics Product
Table 91. Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Topgen Recent Development
Table 93. Geneis Company Details
Table 94. Geneis Business Overview
Table 95. Geneis Prostate Cancer Molecular Diagnostics Product
Table 96. Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Geneis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Prostate Cancer Molecular Diagnostics Picture
Figure 2. Global Prostate Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Prostate Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Prostate Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Prostate Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Prostate Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prostate Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prostate Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Prostate Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Qiagen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Foundationmedicine Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Genetech Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. Gpmedical Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 53. Premed Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 54. Berryoncology Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 55. Gene+ Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 56. Annoroad Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 57. Topgen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 58. Geneis Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Prostate Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Prostate Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Prostate Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Prostate Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Prostate Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Prostate Cancer Molecular Diagnostics Market Trends
Table 13. Prostate Cancer Molecular Diagnostics Market Drivers
Table 14. Prostate Cancer Molecular Diagnostics Market Challenges
Table 15. Prostate Cancer Molecular Diagnostics Market Restraints
Table 16. Global Prostate Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Prostate Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Prostate Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Prostate Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Prostate Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Prostate Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Prostate Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Qiagen Company Details
Table 49. Qiagen Business Overview
Table 50. Qiagen Prostate Cancer Molecular Diagnostics Product
Table 51. Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Qiagen Recent Development
Table 53. Foundationmedicine Company Details
Table 54. Foundationmedicine Business Overview
Table 55. Foundationmedicine Prostate Cancer Molecular Diagnostics Product
Table 56. Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Foundationmedicine Recent Development
Table 58. Genetech Company Details
Table 59. Genetech Business Overview
Table 60. Genetech Prostate Cancer Molecular Diagnostics Product
Table 61. Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Genetech Recent Development
Table 63. Gpmedical Company Details
Table 64. Gpmedical Business Overview
Table 65. Gpmedical Prostate Cancer Molecular Diagnostics Product
Table 66. Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Gpmedical Recent Development
Table 68. Premed Company Details
Table 69. Premed Business Overview
Table 70. Premed Prostate Cancer Molecular Diagnostics Product
Table 71. Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Premed Recent Development
Table 73. Berryoncology Company Details
Table 74. Berryoncology Business Overview
Table 75. Berryoncology Prostate Cancer Molecular Diagnostics Product
Table 76. Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Berryoncology Recent Development
Table 78. Gene+ Company Details
Table 79. Gene+ Business Overview
Table 80. Gene+ Prostate Cancer Molecular Diagnostics Product
Table 81. Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Gene+ Recent Development
Table 83. Annoroad Company Details
Table 84. Annoroad Business Overview
Table 85. Annoroad Prostate Cancer Molecular Diagnostics Product
Table 86. Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Annoroad Recent Development
Table 88. Topgen Company Details
Table 89. Topgen Business Overview
Table 90. Topgen Prostate Cancer Molecular Diagnostics Product
Table 91. Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Topgen Recent Development
Table 93. Geneis Company Details
Table 94. Geneis Business Overview
Table 95. Geneis Prostate Cancer Molecular Diagnostics Product
Table 96. Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Geneis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Prostate Cancer Molecular Diagnostics Picture
Figure 2. Global Prostate Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Prostate Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Prostate Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Prostate Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Prostate Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Prostate Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Prostate Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Prostate Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Qiagen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Foundationmedicine Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Genetech Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. Gpmedical Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 53. Premed Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 54. Berryoncology Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 55. Gene+ Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 56. Annoroad Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 57. Topgen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 58. Geneis Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Cutting Machines for Diamond Market Research Report 2025
Jul 18, 25
Global RF Shielded Enclosures Market Research Report 2025
Jul 18, 25
Global Padel Court Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232